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iments with the hemodialysis blood tubing revealed that hemo-Multistate outbreak of hemolysis in hemodialysis patients
lysis was caused by increased pressure on erythrocytes as theytraced to faulty blood tubing sets.
passed through the partially occluded hemodialysis bloodBackground. Hemolysis associated with hemodialysis is
tubing.rare. The most frequent causes of hemodialysis-associated he-
Conclusions. Our investigation traced the multiple hemoly-molysis are chemical contamination, heat, or mechanical injury
sis outbreaks to partially occluded hemodialysis blood tubingof erythrocytes from occluded or kinked hemodialysis blood
produced by a single manufacturer. On May 25, 1998, thelines. When patients in three states developed hemolysis while
manufacturer issued a voluntary nationwide recall of the impli-undergoing hemodialysis between May 13 and 23, 1998, an inves-
cated lots of hemodialysis blood tubing cartridge sets.tigation was initiated.
Methods. A case-patient was defined as any patient at
healthcare facilities A (Nebraska), B (Maryland), or C (Massa-
chusetts) during May 13 through 23, 1998 (epidemic period),
Annually, over 225,000 persons with end-stage renalwho had hemolysis diagnosed $48 hours after undergoing he-
disease undergo long-term hemodialysis in the Unitedmodialysis. To identify case-patients and to determine back-
ground rates, the medical records of patients from facilities States and Canada [1, 2]. Hemolysis, or premature break-
A, B, and C who were undergoing hemodialysis during the down of erythrocytes, associated with hemodialysis is
epidemic and pre-epidemic (that is, May 5 through 19, 1998) rarely reported [3, 4]. Causes of hemolysis include oxidiz-periods were reviewed. Experiments simulating hemodialysis
ing agents (for example, copper, zinc, chloramine, or ni-with the same lot numbers of hemodialysis blood tubing car-
trate contamination of the dialysate), reducing agents (fortridge sets used on case- and control-patients were conducted.
Results. The rates of hemolysis among patients at facilities example, formaldehyde used to disinfect reprocessed di-
A, B, and C were significantly higher during the epidemic than alyzers or water treatment systems), osmolar insults (for
the pre-epidemic period (13 out of 118 vs. 0 out of 118, P , example, hypotonic dialysate), the use of dialysate ex-0.001; 12 out of 298 vs. 0 out of 298, P 5 0.001; and 5 out
ceeding 428C; mechanical injury from occluded bloodof 62 vs. 0/65, P 5 0.03, respectively). All case-patients had
hemolysis. Twenty (66%) had hypertension. Eighteen (60%) pumps, arterial line collapse, or kinked or obstructed he-
had abdominal pain, and 10 (36%) were admitted to an inten- modialysis tubing [3–5]; or excessive uremia at the initia-
sive care unit. There were two deaths. The only commonality tion of dialysis [5]. When outbreaks of hemolysis in he-
among the three outbreaks was the use of the same lot of
modialysis patients were reported from seven dialysisdisposable hemodialysis blood tubing from one manufacturer.
centers in three states, we initiated an investigation.Examination of the implicated hemodialysis blood tubing car-
tridge sets revealed narrowing of an aperture through which
blood was pumped before entering the dialyzers. In vitro exper-
METHODS
Definition and ascertainment of casesKey words: hemodialysis tubing, hemolysis, dialyzer blood lines,
epidemic. A case-patient was defined as any patient at facilities
A (2 in Nebraska), B (4 in Maryland), or C (1 in Massa-Received for publication May 27, 1999
chusetts) who had hemolysis diagnosed $48 hours afterand in revised form October 22, 1999
Accepted for publication November 2, 1999 undergoing hemodialysis during the defined study peri-
ods (Table 1). A control-patient was defined as any pa-Ó 2000 by the International Society of Nephrology
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Table 1. Study period definitions and attack rates, by facility, May 5–23, 1998
Study period, 1998 Attack rate
Facility Pre-epidemic Epidemic Pre-epidemic Epidemic P value
A (Nebraska) May 5–12 May 13–20 0/118 13/118 ,0.001
B (Maryland) May 10–17 May 18–23 0/298 12/298 0.001
C (Massachusetts) May 12–19 May 20–22 0/65 5/62 0.03
tient undergoing hemodialysis during the study periods Prevention (CDC) for testing. Free and total chlorine
concentrations were determined by spectrophotometerat facilities A, B, or C who did not develop hemolysis
$48 hours after undergoing that procedure. Hemolysis and by the N,N-Diethyl-p-phenylenediamine (DPD)
method [6, 7]. Since there is no direct test for the pres-was defined as discolored, pink serum visualized in a
spun serum sample (that is, “pink test”) collected from ence of combined chlorine (chloramine), chloramine
concentrations were determined indirectly by the follow-the dialysis patient or noted by the hematology clinical
laboratory personnel. Hypertension was defined as an ing formula: Combined chlorine 5 Cl(total) 2 Cl(free). To
estimate the adequacy of chloramine removal by theincrease of $30 mg Hg from baseline systolic blood pres-
sure. carbon filters in the water treatment system, empty bed
contact time for the carbon filters was measured. WaterTo identify additional case-patients and to determine
the background rate of hemolysis at health-care facility and dialysate samples were obtained and sent to an inde-
pendent laboratory to determine trace elements and bac-A, the medical records of all patients undergoing hemo-
dialysis during the study period were reviewed. At facili- terial concentration and/or endotoxin levels. At all four
facilities in Maryland and one in Massachusetts, the totalties B and C, a random sample of medical records of
patients undergoing hemodialysis during the study pe- chlorine and chloramine levels were measured in product
water.riod was reviewed. In addition, staff at all three facilities
were interviewed to identify patients with hemolysis dur-
Additional experiments and studiesing the study period.
Evaluation of blood tubing sets. To evaluate the role
Analytical epidemiology of blood tubing sets [Cobe Centrysystem 3; Gambro
Healthcare, Inc., Lakewood, CO, USA (note that the useA case-control study was conducted at each healthcare
facility. Control-patients were randomly selected during of trade names is for identification purposes only and
does not imply endorsement by the Public Health Servicethe respective epidemic periods. Medical records were
evaluated for demographics, underlying disease, dialysis or the U.S. Department of Health and Human Services)],
the cartridge’s blood tubing thickness was measured byschedule, dialysis machine, dialyzer used, medication his-
tory, signs and symptoms of illness, and medical staff microscopy, the hardness or density by durameter (In-
stron Co., Canton, MA, USA), and tensile strength byinvolved in the patients’ care during the dialysis session.
A variety of laboratory results were reviewed, including, Instron machine (Instron Co.) on samples of blood tub-
ing sets from lot numbers in use at each of the facilitieshemoglobin, hematocrit, platelets, leukocytes, serum
glutamic oxalacetic transaminase (SGOT), bilirubin, and (that is, 04D15309, 04D153187, and 04D153188; Fig. 1).
Simulated human hemodialysis studies. To evaluateamylase.
the role of different blood tubing sets on hemolysis, in
Procedural review vitro experiments were conducted that simulated human
hemodialysis. Packed erythrocytes (PRBCs; 100 cc) wereIn all facilities, water quality and possible water system-
related exposures and water treatment system and prac- mixed with 200 cc of 0.9% sodium chloride (Baxter
Healthcare Corp., Deerfield, IL, USA) and then circu-tices, including disinfection, distribution, and storage
lated in 11 different Cobe Centrysystem 3 dialysis ma-procedures, were examined and reviewed. Disinfection
chines (Gambro Healthcare) using 11 different Cobeand maintenance of reprocessed dialyzers and dialysis
blood tubing sets [6 of lot number 03D153188, 3 new ofmachines were observed, as were patient dialysis sessions.
lot number 04D15309, and 2 implicated tubing sets of
Laboratory studies 04D15309 (previously used on case-patients during ses-
sions in which hemolysis occurred); Gambro Healthcare]At one healthcare facility in Nebraska, the total chlo-
rine and chloramine levels of water precarbon and post- and standard dialysate [2.0 milliequivalent (mEq) K/2.5
mEq Ca/35 mEq HCO3; Gambro Healthcare] and dialyz-carbon adsorption were determined every 2 hours for
10 hours on May 24, 1998. These samples were refriger- ers (Baxter CA-HP 170).
An AV Fistula Set (Baxter) with a 16G 3 2.5 cmated and sent to the Centers for Disease Control and
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needle was used to access the injection port of the bag
containing the PRBC-0.9% sodium chloride mixture.
The needle was secured to the port, and the other end
was attached to the cartridge set venous tubing, which
then was interlocked with the dialyzer. Next, the arterial
line of the cartridge set was connected to a Solution Set
Flashball Device 70 intravenous (IV) line (Baxter).
The IV line was placed into the tubing access port
of the bag containing the PRBC-0.9% sodium chloride
mixture and secured in place. Dialysis flow parameters
were similar to those used in patients; blood flow was
set at 300 cc/h and dialysate flow at 550 cc/min, and
heparin (Elkins-Sinn, Inc., Cherry Hill, NJ, USA) was
infused at 200 U/h. After 30 minutes, 5 mL of blood
were collected from the arterial line and injected into a
Serum Separator Tube (SST; Becton Dickinson and Co.,
Franklin Lakes, NJ, USA), centrifuged for 15 minutes
at 15,000 revolutions per minute, and then examined for
signs of hemolysis by examining the color of the serum
(pink test).
Fig. 1. Schematic diagram of hemodialysis cassette and blood tubing
set. The connectors, casette, slips and tubing can be seen. Color repro- Statistical analysis
duction was made possible by the Centers for Disease Control and
Data were entered onto standardized forms, enteredPrevention, Atlanta, GA, USA.
into a computer, and analyzed with Epi Info 6.04 soft-
Fig. 2. View of the dialysis machine showing Area A, the obstructed hemodialysis cassette and blood tubing set. Color reproduction was made
possible by the Centers for Disease Control and Prevention, Atlanta, GA, USA.
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Table 2. Comparison of case- and control-patients in facilities in Massachusetts, Nebraska, and Maryland during May 13–23, 1998
Case-patients Control-patients Odds ratio
Variables (N 5 30) (N 5 60) 95% CI P value
Continuous; median (range)
Age years 67 (43–85) 61 (22–93) NS
Dialysis
Onset of dialysis years 3 (,1–8) 2 (.1–15) NS
Length of dialysis sessions minutes 146.5 (53–272) 240 (103–301) ,0.0001a
Maximal venous pressure mm Hg 196 (84–350) 260 (156–356) 0.002b
Category; number %
Gender female 14 (47%) 29 (48%) NS
Symptoms
Hypertension 20 (66%) 2 (3.3%) 58.00 (10.4–428) ,0.001
Abdominal pain 18 (60%) 1 (1.7%) 85.50 (10.5–1954) ,0.001
Nausea 17 (59%) 0 (0%) undefined ,0.001
Vomiting 12 (40%) 0 (0%) undefined ,0.001
Chest pain 12 (40%) 1 (1.7%) 39.33 (4.69–866) ,0.001
Shortness of breath 8 (27%) 0 (0%) undefined ,0.001
Diarrhea 6 (20%) 0 (0%) undefined 0.001
Back pain 4 (14%) 0 (0%) undefined 0.01
Rash 3 (10%) 2 (3.3%) NS NS
aData available for 18 case- and 46 control-patients
bData available for 18 case- and 47 control-patients
ware [8]. Categorical variables were compared by using correlation between length of dialysis treatment session
and severity of symptoms.the Fisher’s exact or chi-square tests and odds ratios
(OR), and 95% confidence intervals (95% CI) were cal- All case-patients had laboratory-confirmed hemolysis.
Lower than normal hemoglobin and hematocrit wereculated. Wilcoxon’s test was used to compare continuous
variables. noted for the majority of case-patients tested and above
normal values for those tested for total bilirubin, SGOT,
and serum amylase (Table 3).
RESULTS
Descriptive epidemiology Comparison of case- and control-patients
There were no significant differences between case-Thirty patients met the case definition. Two patients
died. The rates of hemolysis at facilities A, B, and C and control-patients in age, gender, medications received,
or underlying disease. However, case-patients were morewere all significantly higher during the epidemic than
pre-epidemic periods (Table 1). The attack rates of he- likely than controls to have a shorter treatment session,
lower maximum venous pressure, or a variety of signsmolysis varied from 4 to 11% at the three facilities.
and symptoms, including abdominal pain, nausea, vom-
Case-patient characteristics iting, or chest pain (Table 2).
Case-patients ranged in age from 43 to 85 (median 67)
Procedure reviewyears and 14 out of 30 (47%) were female (Table 2).
The median number of years since the onset of dialysis At each healthcare facility, the water treatment sys-
tem, including disinfection, distribution, and storage pro-treatment was three years (range ,1 to 8). Nineteen
(63%) case-patients were dialyzed on a Monday, Wednes- cedures, met the recommended standards. The observa-
tion of disinfection and maintenance of reprocessedday, and Friday schedule. The 30 case-patients were dia-
lyzed on 29 different dialysis machines. Eleven (37%) dialyzers and dialysis machines and a patient dialysis
session revealed no breaks in aseptic techniques. Dialysisof 30 case-patients were dialyzed with reprocessed dia-
lyzers. After the onset of symptoms, 28 case-patients machines differed between patients and facilities. All
facilities used Cobe blood tubing sets. Blood tubing setswere admitted to a hospital. One refused admission, and
one did not require admission. Of the 28 hospitalized of several lot numbers were available at each facility,
and one lot, #309, was used at all centers. At facility A,case-patients, 10 (36%) were admitted to an intensive
care unit. Nine (30%) case-patients required at least one lot #309 was received on May 11, and the first patient
developed hemolysis on May 13. At facility B, lot #309blood transfusion. The median length of dialysis session
for case-patients was 147 (range of 53 to 272) minutes. was received on May 18, and the first case-patients diag-
nosed with hemolysis was on May 18. At facility C, lotCase-patient signs and symptoms varied and included
hypertension, abdominal pain, nausea, vomiting, chest #309 was received on May 18 and the first case-patient
diagnosed on May 20.pain, shortness of breath, or diarrhea. There was no
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Table 3. Laboratory results from case-patients admitted to hospitals in Nebraska, Maryland, and Massachusetts, May 1998
No. of case-patients in normal range
No. of Case-patient laboratory values
Laboratory Test case-patients median (range) Below Within Above
Hemoglobin g/dL 28 10.7 (7.1–14.2) 23 (82%) 5 (18%) —
Hematocrit1 (PCV) % 26 29.8 (14.1–41.4) 23 (88%) 3 (12%) —
Platelets thousand/mm3 25 222 (51–613) 5 (20%) 16 (64%) 4 (16%)
White blood cells thousand/mm3 24 11.2 (2.1–31.7) 1 (4%) 10 (42%) 13 (54%)
Bilirubin, total mg/dL 21 2.4 (0.6–31) — 6 (29%) 15 (71%)
Serum glutamic oxalacetic transaminase (SGOT) U/L 19 188 (13–5100) — 1 (5%) 18 (95%)
Amylase U/dL 16 403 (3.0–2939) — 4 (25%) 12 (75%)
Protime seconds 12 12.2 (1.9–30.2) 2 (17%) 6 (50%) 4 (33%)
Partial thromboplastin time (PPT) seconds 11 29.9 (18.7–200) 1 (9%) 7 (64%) 3 (27%)
Haptoglobin mg/dL 11 21 (8.0–237) 4 (36%) 6 (55%) 1 (9%)
Lactic dehydrogenase (LDH) U/L 7 3164 (1810–11015) — — 7 (100%)
Laboratory studies a blood clot was responsible for the obstruction. Uroki-
nase 5000 IU (Abbott Laboratories, North Chicago, IL,All chlorine and chloramine assays of water from
USA) was injected; however, the obstruction did nottreatment systems at the facilities were within the Ameri-
clear, and we were unable to obtain a blood sample.can Association for the Advancement of Medical Instru-
Visual examination of the blood tubing set revealed nar-mentation (AAMI) standards [9]. The microbial, endo-
rowing of an aperture through which blood was pumpedtoxin, and trace element levels also were within AAMI
under pressure before entering the dialyzer. In the bloodor other recommended standards [9] at health care facil-
tubing set of the second case-patient, the blood circulatedity A (facilities B and C were not tested).
very slowly and soon stopped because of the same ob-
Additional experiments and studies struction. The blood sampled after circulation showed
gross hemolysis within 30 minutes of the initiation ofDialysis blood tubing assessments. Since the investiga-
circulation.tions at all facilities suggested that water, dialysis ma-
chines, dialyzers, and disinfectant or chemical exposures
Manufacturer’s plant reviewwere unlikely to be the source of the outbreaks and that
The implicated blood tubing had been produced in athe same manufacturer’s blood tubing sets, including the
Gambro facility in Tijuana, Mexico. At the end of Marchlot numbers, were used at all outbreak facilities, our
1998, Gambro Inc. introduced a new tool (that is, mold)investigation focused on the blood tubing sets as the
in their manufacturing plant to produce the cartridgepossible source of the hemolysis.
portion of the blood tubing sets. On April 10, 1998, theThe dialysis blood tubing sets are composed of four
tool malfunctioned. It was repaired the same day anddifferent components: connectors, cassette, clips, and
was placed back on the production line. However, theretubing. There are eight different tubing lines that are
continued to be a problem in the cooling mechanism ofattached to the two-chambered cassette (Figs. 1 and 2).
the tool. This led to the production of cartridges thatThe tubing component of the blood tubing sets from lot
had a constriction of the lumen at the point where thenumbers 04D15309 and 04D153187 had similar density,
arterial blood tubing connected to the cartridge. Gambrothickness, and tensile strength.
Inc. estimated that of the 3000 cartridges manufactured
Simulated human hemodialysis studies with this tool, approximately 300 (10%) were defective.
This estimate came from an examination of 61 in-houseDuring the 11 mock dialysis sessions, we collected 10
cassette and blood tubing sets of implicated lot numberblood samples postdialysis; all 10 had positive pink tests.
(04D15309), of which 7 (11%) of the tubing lot wereSamples obtained from the machines using the 04D15309
defective. It was estimated that the degree of occlusionblood tubing sets, both new and implicated, appeared to
in the defective cassette and tubing varied between 20have a greater hemolysis (that is, a deeper red color).
to 80%. The 300 defective cartridges went to the produc-Running the experiment using blood tubing sets that
tion of Cobe Centrysystem 3 blood tubing sets of lothad been set aside after being used on two of the case-
numbers 04D15309, 04D15308, and 04D15310.patients (that is, implicated blood tubing sets), we were
able to prime and circulate saline through both. How-
Product recallever, when we attempted to circulate the blood mixture
On May 25, 1998, Gambro Healthcare, Inc. issuedthrough the first blood tubing set, it would not circulate
a voluntary nationwide recall of specific lots of Cobeand appeared to be obstructed at a specific point in the
tubing, area A (Figs. 2 and 3). It was thought that perhaps Centrysystem 3 Blood Tubing Sets (including lot number
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04D15309, 04D15308, and 04D15310) under catalog Our investigation documented that the severity of the
adverse reaction in case-patients varied. Of our 28 case-number 003-210-500. On June 10, following additional
reports (and an additional 3 deaths) in Alabama and patient admissions, the severity of side effects varied
from some requiring blood transfusion to intensive careNew Jersey, the recall was expanded to all Cobe Centry-
system 3 Blood Tubing Sets and Hemodialysis Kits lot unit admission. We found no association between out-
numbers with catalog numbers 003109-400, 003109-410, come and the length of time the patient was dialyzed
003110-500, 003111-500, 003112-500, 003113-500, 003114- with the defective blood tubing set. However, when we
500, 003210-500, 003212-500, 003101-000, and 003212-515. examined the defective blood tubing, the degree of occlu-
sion varied from set to set. That variation in the degree
of blockage at area A of the defective tubing could ex-DISCUSSION
plain the differences in degree of hemolysis and variable
Outbreaks of hemolysis associated with hemodialysis severity of adverse outcomes in case-patients. Patients
occurred simultaneously at seven dialysis centers in three exposed to the more occluded blood tubing sets may
states. Although hemolysis in dialysis patients has been have had more severe hemolysis and symptoms, whereas
previously reported, they remain rare events and pre- those exposed to tubing with less occlusion may have
viously have been limited to a single center [3–5]. We had less hemolysis and fewer symptoms.
began our epidemiologic and laboratory investigation When Gambro Inc. detected the faulty tool at the
evaluating the most frequent reported causes of hemodi- manufacturing plant and reported that 10% of the car-
alysis-associated hemolysis. Our data documented that tridge blood tubing sets were defective, with the degree
the hemolysis was not associated with abnormal levels of occlusion varying between 20 to 80%, it was clear
of trace elements, bacteria, endotoxin, chlorine, or chlo- why more patients did not develop hemolysis. Many were
ramine in the treated water at these centers or mechani- dialyzed with normal #309 blood tubing sets. Thus, the
cal problems from faulty dialyzers or occluded or kinked attack rate of 4 to 11% at the different facilities and the
hemodialysis blood tubing. varying degree of hemolysis and symptoms among the
Upon review, the only commonality among the out- patients are consistent with the finding that the propor-
breaks at the involved centers was use of the same lot tion of blood tubing affected and the extent of occlusion
(number 04D15309) of disposable hemodialysis blood of the tubing varied.
tubing sets from one manufacturer. Although the exact This outbreak demonstrates the importance of surveil-
lot numbers of blood tubing used in each patient were lance for adverse reactions in hemodialysis centers and
not recorded at any of the locations, some of the blood the value of a coordinated public health investigation.
tubing sets associated with hemolysis in case-patients Our epidemiologic and laboratory investigation traced
had been saved at healthcare center A. the outbreak of hemolysis to defective hemodialysis
Because we were unable to use an in vivo model to blood tubing sets produced by a single manufacturer.
run the hemodialysis experiments and used a PRBC and The prompt recognition of adverse events by nephrolo-
sodium chloride mixture as our experimental patient, gists and their prompt reporting of these adverse events
hemolysis was noted in the 10 blood samples obtained to the manufacturer, State health departments, Centers
from both the implicated and nonimplicated blood tub- for Disease Control, and the Food and Drug Administra-
ing sets. However, a greater degree of hemolysis was noted tion led to a comprehensive investigation that rapidly
in blood samples obtained from lot number 04D15309. (within 3 days) identified the source of the outbreak and
Careful visual examination of the implicated blood tub- resulted in the voluntary withdrawal of the implicated
ing sets revealed narrowing of an aperture through which blood tubing sets. This coordinated public health investi-
blood was pumped under pressure before entering the gation and intervention, including the cooperation and
dialyzer. We hypothesize that hemolysis occurred be- assistance of Gambro Inc., prevented greater mortality
cause of increased pressure on erythrocytes as they passed and morbidity from occurring because these blood tub-
through the semioccluded blood tubing. The Cobe Cen- ing sets had been distributed to centers throughout the
trysystem 3 dialysis machine did not sound an alarm with United States.
this partially occluded tubing because the machine lacks
Reprint requests to Centers for Disease Control and Prevention,a pressure monitor at the point in which increased pres-
Hospital Infections Program, William R. Jarvis, M.D., 1600 Cliftonsure was likely to have occurred. The reduced maximum
Road N.E., Mail Stop-E69, Atlanta, Georgia 30333, USA
venous pressure observed in some case-patients may have
resulted from reduced blood flow through the dialyzer,
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